2 Healthcare Stocks Worth Your Attention and 1 We Ignore [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry's 1.8% return has trailed the S&P 500 by 3.1 percentage points. Despite the lackluster result, a few diamonds in the rough can produce earnings growth no matter what, and we started StockStory to help you find them. Keeping that in mind, here are two healthcare stocks boasting durable advantages and one we're swiping left on. One Healthcare Stock to Sell: NeoGenomics (NEO) Market Cap: $1.06 billion Operating a network of CAP-accredited and CLIA-certified laboratories across the United States and United Kingdom, NeoGenomics (NASDAQ:NEO) provides specialized cancer diagnostic testing services, including genetic analysis, molecular testing, and pathology consultation for oncologists and healthcare providers. Why Do We Avoid NEO? Revenue growth over the past five years was nullified by
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura IntegrationBusiness Wire
- NeoGenomics (NEO) Q4 2024 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026Business Wire
- NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026Business Wire
NEO
Earnings
- 2/17/26 - Beat
NEO
Sec Filings
- 4/6/26 - Form DEFA14A
- 4/6/26 - Form ARS
- 4/6/26 - Form DEF
- NEO's page on the SEC website